#virology #HIV #Gilead #Biktarvy #viralsuppression #ARTISTRY1 #ARTISTRY2 #ConferenceonRetrovirusesandOpportunisticInfections #bictegravir #lenacapavir #multitabletantiretroviralregimens #TheLancet #ARTISTRYdata #integrasestrandtransferinhibitor #capsidinhibitor
zurl.co/T0S4R
zurl.co/T0S4R
Gilead data show investigational HIV combination maintains viral suppression - PharmaTimes
New phase 3 results highlight potential alternative for adults switching from complex regimens
pharmatimes.com
March 9, 2026 at 11:56 AM